1. Improved survival in chronic myeloid leukemia since the introduction of imatinib therapy: a single-institution historical experience;Kantarjian;Blood,2012
2. Clinical and hematological features of 335 patients of chronic myelogenous leukemia diagnosed at single centre in northern Pakistan;Bhatti;Clin Med. Blood Dis,2012
3. World Chronic Myeloid Leukemia Day: Leukemia common among younger Pakistanis. Express Tribune Web Archives 26 September 2013:5. Available at: https://tribune.com.pk/story/609805/world-chronic-myeloid-leukemia-day-leukemia-common-among-younger-pakistanis. Accessed June 29, 2022.
4. Response and adverse effects of nilotinib in imatinib-resistant chronic myeloid leukemia patients: data from a developing country;Hussain;Clinical therapeutics,2015
5. Yusufzai Mushtaq. KP govt to continue providing free treatment to poor cancer patients. The News International. 23 September 2019. Available at: https://www.thenews.com.pk/print/530827-kp-govt-to-continue-providing-free-treatment-to-poor-cancer-patients. Accessed July 3, 2022.